Pre-commercial, small and emerging life sciences companies have a lot of priorities they must juggle—from developing and strengthening commercial operations to navigating product approval timelines. Many times, transparency reporting requirements are the last thing an organization wants to think about. However, these requirements can be complex and can cause a headache for a company not prepared or without the resources to manage them effectively.
Listen as MediSpend’s Chief Commercial Officer, Seth Houston, and MediSpend’s Director of Client Services, Lucas Croteau, discuss how to build an effective, scalable transparency reporting program to meet requirements in the U.S. and abroad.
To learn more, please provide us your information to access the webinar “Building An Effective Transparency Reporting Program (From the Ground Up).” In this webinar, Seth and Lucas outline current transparency reporting requirements and discuss how organizations can use a flexible and scalable approach to take the burden out of meeting those requirements.
About MediSpend
MediSpend is a global technology company providing best-in-class solutions that enable life science companies to compliantly manage high-risk business functions through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands.